Details of the Drug
General Information of Drug (ID: DM3MDOL)
| Drug Name |
Phenazopyridine
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
phenazopyridine; Pyridiate; Gastracid; 94-78-0; Baridium; Pyrazofen; Urogesic; 3-(Phenylazo)-2,6-pyridinediamine; Geridium; Gastrotest; Viridium; 2,6-Pyridinediamine, 3-(phenylazo)-; Pyridacil; Fenazopiridina; Eridium; 2,6-Diamino-3-phenylazopyridine; Phenazopyridinum; 2,6-Diamino-3-(phenylazo)pyridine; Phenazopyridine [INN:BAN]; UNII-K2J09EMJ52; Phenazopyridinum [INN-Latin]; Fenazopiridina [INN-Spanish]; NSC 145895; HSDB 3153; EINECS 202-363-2; BRN 0184497; 3-(phenyldiazenyl)pyridine-2,6-diamine; Pyridine, 2,6-diamino-3-(phenylazo)-
|
||||||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||||||
| Affected Organisms |
Humans and other mammals
|
||||||||||||||||||||||||||
| ATC Code | |||||||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||||||||||
| Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | ||||||||||||||||||||||||||
| Repurposed Drugs (RPD) | Click to Jump to the Detailed RPD Information of This Drug | ||||||||||||||||||||||||||
References

